显示 发表于 2025-3-25 07:18:33

Book 2021inoblastoma, malignant melanoma and lymphoma in some detail while covering tumors of lids and conjunctiva briefly. Separate chapters are devoted to the pathology of retinoblastoma, genetics of retinoblastoma and malignant melanoma. Each chapter is profusely illustrated. The book provides state-of-th

奇怪 发表于 2025-3-25 11:08:12

http://reply.papertrans.cn/71/7006/700578/700578_22.png

Narcissist 发表于 2025-3-25 14:09:48

http://reply.papertrans.cn/71/7006/700578/700578_23.png

aspect 发表于 2025-3-25 18:01:11

Eyelid Tumors: The Entire Spectrum,ive margins. This prevents recurrences and reduces morbidity and mortality. Adjuvant therapy is indicated in selected case scenarios. The newer development of targeted therapy in malignant eyelid tumors seems promising.

Spinal-Tap 发表于 2025-3-25 22:56:10

http://reply.papertrans.cn/71/7006/700578/700578_25.png

组装 发表于 2025-3-26 02:25:55

Leukemia and Eye,these patients are immunosuppressed and are at risk of opportunistic infections. The diagnosis is established with imaging studies, orbital biopsy, peripheral smear, and bone marrow biopsy. Systemic chemotherapy remains the mainstay of treatment. Early diagnosis and prompt referral to the oncologist is life-saving.

VEIL 发表于 2025-3-26 04:35:58

Orbital Tumors,gery, malignant tumors are managed by using one or more of the various modalities of treatment available, as deemed appropriate by the treating ocular oncologist in conjunction with a medical oncologist.

控制 发表于 2025-3-26 09:42:17

Genetics of Retinoblastoma,fied. This chapter entails the current understanding regarding the genetics of retinoblastoma including the type of inheritance, molecular genetics, genetic variations, genetic testing and the role of preimplantation and prenatal diagnosis in proper counselling of the families.

GLUT 发表于 2025-3-26 15:02:39

http://reply.papertrans.cn/71/7006/700578/700578_29.png

外向者 发表于 2025-3-26 19:36:37

http://reply.papertrans.cn/71/7006/700578/700578_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Ocular Tumors; H. V. Nema,Nitin Nema Book 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature